Recombinant erythropoietin in humans has a prolonged effect on circulating erythropoietin isoform distribution.
The membrane-assisted isoform immunoassay (MAIIA) quantitates erythropoietin (EPO) isoforms as percentages of migrated isoforms (PMI). We evaluated the effect of recombinant human EPO (rhEPO) on the distribution of EPO isoforms in plasma in a randomized, placebo-controlled, double-blinded, cross-ove...
Main Authors: | Niels Jacob Aachmann-Andersen, Søren Just Christensen, Kristian Lisbjerg, Peter Oturai, Anne-Kristine Meinild-Lundby, Niels-Henrik Holstein-Rathlou, Carsten Lundby, Niels Vidiendal Olsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4204994?pdf=render |
Similar Items
-
Evaluation of functional erythropoietin receptor status in skeletal muscle in vivo: acute and prolonged studies in healthy human subjects.
by: Britt Christensen, et al.
Published: (2012-01-01) -
Erythropoietin treatment enhances mitochondrial function in human skeletal muscle
by: Ulla ePlenge, et al.
Published: (2012-03-01) -
The ergogenic effect of recombinant human erythropoietin on VO2max depends on the severity of arterial hypoxemia.
by: Paul Robach, et al.
Published: (2008-08-01) -
Hematological Adaptations to Prolonged Heat Acclimation in Endurance-Trained Males
by: Laura Oberholzer, et al.
Published: (2019-11-01) -
Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial
by: Lejla Sjanic Schmidt, et al.
Published: (2018-04-01)